Page last updated: 2024-11-04

sarpogrelate and Coronary Restenosis

sarpogrelate has been researched along with Coronary Restenosis in 3 studies

sarpogrelate: structure given in first source

Coronary Restenosis: Recurrent narrowing or constriction of a coronary artery following surgical procedures performed to alleviate a prior obstruction.

Research Excerpts

ExcerptRelevanceReference
"Sarpogrelate treatment reduces restenosis after coronary stenting, which suggests that serotonin released from activated platelets may play an important role in stent restenosis."2.71Sarpogrelate treatment reduces restenosis after coronary stenting. ( Fujita, M; Ho, M; Ishii, K; Miki, O; Miwa, K; Miyamoto, A; Mizuno, K; Tsukahara, R, 2003)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lee, SA1
Suh, JW1
Park, JJ1
Yoon, CH1
Cho, YS1
Youn, TJ1
Chae, IH1
Kim, HS1
Kim, SH1
Choi, DJ1
Fujita, M1
Mizuno, K1
Ho, M1
Tsukahara, R1
Miyamoto, A1
Miki, O1
Ishii, K1
Miwa, K1
Tamura, A1
Watanabe, T1
Shinozaki, K1
Kotoku, M1
Yano, S1
Kadota, J1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Multicenter Randomized Trial Evaluating the Efficacy of Sarpogrelate on Ischemic Heart Disease After Drug-eluting Stent Implantation in Patients With Diabetes Mellitus or Renal Impairment[NCT02294643]Phase 3220 participants (Actual)Interventional2009-04-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

3 trials available for sarpogrelate and Coronary Restenosis

ArticleYear
Study design of the influence of SErotonin inhibition on patients with RENAl impairment or diabetes undergoing drug-eluting stent implantation (SERENADE) study: A multicenter, open-label, prospective, randomized study.
    Contemporary clinical trials, 2015, Volume: 43

    Topics: Aspirin; Clopidogrel; Coronary Angiography; Coronary Restenosis; Diabetes Mellitus; Drug Therapy, Co

2015
Sarpogrelate treatment reduces restenosis after coronary stenting.
    American heart journal, 2003, Volume: 145, Issue:3

    Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Cell Division; Coronary Angiography;

2003
Comparison of sarpogrelate and ticlopidine in bare metal coronary stent implantation.
    International journal of cardiology, 2008, May-07, Volume: 126, Issue:1

    Topics: Aged; Coronary Restenosis; Coronary Thrombosis; Coronary Vessels; Female; Follow-Up Studies; Humans;

2008